161 related articles for article (PubMed ID: 14755912)
21. Celecoxib (Celebrex): 1 year later.
McMorran M; Morawiecka I
CMAJ; 2000 Apr; 162(7):1044-6, 1048-50. PubMed ID: 10763409
[No Abstract] [Full Text] [Related]
22. Ketorolac-associated upper gastrointestinal hemorrhage.
Quigley EM; Ruh P
Am J Gastroenterol; 1994 Feb; 89(2):287-9. PubMed ID: 8304326
[No Abstract] [Full Text] [Related]
23. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
24. [This time the blood did not come from the stomach].
Stiefelhagen P
MMW Fortschr Med; 2015 Sep; 157(16):22. PubMed ID: 26783609
[No Abstract] [Full Text] [Related]
25. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
[TBL] [Abstract][Full Text] [Related]
26. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
[TBL] [Abstract][Full Text] [Related]
27. [Anaphylactic shock induced by celecoxib].
Habki R; Vermeulen C; Bachmeyer C; Charoud A; Mofredj A
Ann Med Interne (Paris); 2001 Sep; 152(5):355. PubMed ID: 11593149
[No Abstract] [Full Text] [Related]
28. Celecoxib and CVS risk--lessons from the APC and PreSAP studies.
Armstrong DJ
Rheumatology (Oxford); 2007 Apr; 46(4):561-2. PubMed ID: 17132690
[No Abstract] [Full Text] [Related]
29. Safety of celecoxib in patients with adverse reactions to nimesulide.
Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
[No Abstract] [Full Text] [Related]
30. [Celecoxib].
Babić-Naglić D
Reumatizam; 2001; 48(2):27-8. PubMed ID: 12476745
[No Abstract] [Full Text] [Related]
31. Does celecoxib use increase the risk of cardiovascular events?
Oviedo JA; Schroy PC
Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088
[No Abstract] [Full Text] [Related]
32. Unique endoscopy findings in collagenous colitis.
Couto G; Bispo M; Barreiro P; Monteiro L; Matos L
Gastrointest Endosc; 2009 May; 69(6):1186-8. PubMed ID: 19152884
[No Abstract] [Full Text] [Related]
33. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
34. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
35. Successful Hemospray treatment for recurrent diclofenac-induced severe diffuse lower gastrointestinal bleeding avoiding the need for colectomy.
Kratt T; Lange J; Königsrainer A; Malek N; Adam P; Bösmüller H; Goetz M
Endoscopy; 2014; 46 Suppl 1 UCTN():E173-4. PubMed ID: 24756280
[No Abstract] [Full Text] [Related]
36. [Fatal colonic hemorrhage--relation to antiphglogistic therapy].
Gustavsson S; Nilsson F
Lakartidningen; 1982 Jul; 79(28-29):2644-5. PubMed ID: 6983012
[No Abstract] [Full Text] [Related]
37. No proof of cross-reactivity between celecoxib and antibiotic sulfonamides.
Smith WB; Mullins RJ
Intern Med J; 2007 May; 37(5):347-8. PubMed ID: 17504291
[No Abstract] [Full Text] [Related]
38. Erectile dysfunction induced probably by celecoxib.
Dhikav V; Gupta S; Anand KS
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):211-2. PubMed ID: 18236511
[No Abstract] [Full Text] [Related]
39. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
Chen JT; Pucino F; Resman-Targoff BH
J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
[TBL] [Abstract][Full Text] [Related]
40. Bleeding colonic ulcer and eosinophilic colitis: a rare complication of nonsteroidal anti-inflammatory drugs.
Jiménez-Sáenz M; González-Cámpora R; Linares-Santiago E; Herrerías-Gutiérrez JM
J Clin Gastroenterol; 2006 Jan; 40(1):84-5. PubMed ID: 16340639
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
